These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10887512)

  • 1. Role of TGF beta in the anti-estrogen response/resistance of human breast cancer.
    Benson JR; Baum M; Colletta AA
    J Mammary Gland Biol Neoplasia; 1996 Oct; 1(4):381-9. PubMed ID: 10887512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-estrogen induced synthesis of transforming growth factor-beta in breast cancer patients.
    Mirza MR
    Cancer Treat Rev; 1991 Jun; 18(2):145-8. PubMed ID: 1804525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.
    Arteaga CL; Koli KM; Dugger TC; Clarke R
    J Natl Cancer Inst; 1999 Jan; 91(1):46-53. PubMed ID: 9890169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the levels of three transforming growth factor beta mRNAs by estrogen and their effects on the proliferation of human breast cancer cells.
    Jeng MH; ten Dijke P; Iwata KK; Jordan VC
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):115-23. PubMed ID: 8143893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition by anti-estrogens and progestins in TGF-beta-resistant and -sensitive breast-tumor cells.
    Kalkhoven E; Beraldi E; Panno ML; De Winter JP; Thijssen JH; Van Der Burg B
    Int J Cancer; 1996 Mar; 65(5):682-7. PubMed ID: 8598322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen-dependent tumors. Overview.
    Ogata E
    Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L; Kharbanda S; Hanfelt J; Kern FG
    Cancer Res; 1998 Jan; 58(2):352-61. PubMed ID: 9443417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.
    Thompson AM; Kerr DJ; Steel CM
    Br J Cancer; 1991 Apr; 63(4):609-14. PubMed ID: 2021547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones and breast cancer in vitro.
    Dickson RB; Thompson EW; Lippman ME
    Hum Cell; 1989 Sep; 2(3):219-30. PubMed ID: 2519209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops.
    de Jong JS; van Diest PJ; van der Valk P; Baak JP
    J Pathol; 1998 Jan; 184(1):44-52. PubMed ID: 9582526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes.
    McClelland RA; Manning DL; Gee JM; Anderson E; Clarke R; Howell A; Dowsett M; Robertson JF; Blamey RW; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 1996; 41(1):31-41. PubMed ID: 8932874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.
    Jeng MH; Langan-Fahey SM; Jordan VC
    Endocrinology; 1993 Jun; 132(6):2622-30. PubMed ID: 8504763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.